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The hepatotoxicity induced by Polygoni Multiflori Radix Praeparata (PM) has aroused
great concern throughout the world. Hence, it is worthwhile to perform studies on the
detoxification with the combined use of medicinal herbs based on the compatibility
theory of traditional Chinese medicine. In this work, the rat model of PM/LPS-induced
idiosyncratic liver injury was used. The effects of Poria, Licorice, and Panax notoginseng
on rats of PM/LPS-induced liver injury were investigated respectively, hoping to find
the most effective herbal medicine to reduce the hepatotoxicity. According to results
of biochemical and histological tests, PM could induce the idiosyncratic hepatotoxicity
of rats which presented modest inflammation triggered by non-injurious dose of
lipopolysaccharide (LPS). We also found that the combined use of Poria and PM in the
ratio of 1:2 could significantly ameliorate the PM/LPS-induced liver injury and systemic
inflammation. Furthermore, UPLC/QTOF-MS-based metabolomics was performed to
identify possible biomarkers and underlying biological pathways. Ten metabolites were
expressed differentially among LPS, PM/LPS, and detoxification-treated groups in terms
of PCA and OPLS-DA analysis, which could be potential biomarkers. MetaboAnalyst
and pathway enrichment analysis revealed that alterations of these metabolites were
primarily involved in three pathways: arginine and proline metabolism, primary bile
acid biosynthesis and sphingolipid metabolism. This research provides systematic
experimental evidences for the hepatoprotective effect of Poria against PM/LPS-induced
liver injury for the first time. And these findings may help better understand the underlying
mechanisms of pathophysiologic changes in PM/LPS-induced liver injury.
Keywords: Polygoni Multiflori Radix Praeparata (PM), Poria, lipopolysaccharide (LPS), idiosyncratic liver injury,
inflammation, compatibility
INTRODUCTION
Due to the limited effectiveness and/or undesirable side effects of standard medical practice,
patients often turn to alternative medicines which are often believed to be safer and sometimes
better as they are “natural” and “wellness” (Seeff et al., 2001; Bent and Ko, 2004). Gradually, the
increasing popularity of traditional Chinese medicine (TCM) becomes a worldwide phenomenon.
Polygoni Multiflori Radix Praeparata (PM) is a well-known tonic TCM that exhibits protective
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effects on aging, immunity, liver and kidney damage,
hyperlipidaemia, and cancer (Lee et al., 2012; Lin et al.,
2015; Huo et al., 2016). However, several cases of PM-induced
hepatotoxicity have been reported, ranging from moderate
elevations of liver enzymes levels, liver failure requiring liver
transplantation to even death (Jung et al., 2011; Wang et al.,
2015). Recently, we found that PM could lead to the failure of
liver microcirculation perfusion (Chang et al., 2014), while it is
still difficult to establish the direct causal relationship between
the hepatic injury and complex constituents even in one single
herbal medicine. It might be more practical to find remedies to
reduce the toxicity rather than delving too deep into possible
causes of hepatic injury.
The compatibility of TCM is the essence of Chinese formulae,
which refers to the combination of two or more herbs based on
their properties and clinical assessments. The combined herbs
will have a better therapeutic effect and fewer side effects than
individual herb or chemical compound (Wang et al., 2012).
Poria is the sclerotium of Poria cocos (Schw.) Wolf. It has long
been used as a sedative and diuretic recorded in An Outline
Treatise of Medical Herbs, “Compendium of Materia Medica”,
as “Poria is the key foundation of PM”, which can guide and
support the actions of the formula to target the pathogenetic
organs or improve therapeutic efficacy (Rios, 2011). Licorice,
another traditional TCM herb, was claimed to coordinate the
drug actions in a prescription as well as minimize the toxicity
of PM when combined (Chang et al., 2015). Panax notoginseng
is also recommended as a typical medicine to invigorate blood
(Li H.Q. et al., 2015; Hung and Wu, 2016). However, there
were few reports on the herb improving liver failure. Although
the combined used of PM and those herbs was recorded in
ancients books, indicating the great potential of detoxification
of the selected herbs based on the compatibility theory, modern
researches with stringent and scientific evidences for such
combination are insufficient.
Our recent study indicated that modest inflammatory episode
induced by non-injurious bacterial lipopolysaccharide (LPS)
potentiated PM-induced liver injury of rats, suggesting that
inflammation could be a factor for idiosyncratic drug toxicity
(Li C.Y. et al., 2015; Tu et al., 2015). Thus, LPS model was
used to evaluate the idiosyncratic hepatotoxicity induced by
PM and detoxification by selected herbs on the basis of TCM
compatibility in this study.
With the development of “omics” sciences, metabolomics
has been developed to be a powerful approach in biomarker
discovery and disease diagnosis (Wishart, 2016). It reveals whole
metabolic profile changes of living systems in response to disease,
pharmacological treatment or toxicological insult based on the
comprehensive analysis of low molecular weight metabolites
in biological systems (Zhang et al., 2015; Guma et al., 2016).
Metabolomics is also compatible with the integrated and systemic
feature of TCM, i.e., being composed of multi-components that
work as a holistic system in the treatment of disease. Indeed,
metabolomics is increasingly applied to understand the toxicity
and mechanisms responsible for the efficacy of TCM (Liu et al.,
2013; Zhang et al., 2015). Here, LPS-stimulated rats were applied
as the model to study PM-induced idiosyncratic liver injury. On
this basis, the combined uses of PM with Poria, Licorice or Panax
notoginseng were investigated, respectively, to determine the
optimal combination for reducing hepatotoxicity. Furthermore,
UPLC/QTOF-MS-based metabolomics was performed to
identify possible biomarkers and biological pathways that might
be involved in. We hope to screen herbs reducing the liver
injury caused by PM/LPS and overall understand the underlying
molecular mechanisms of PM with the screened herb against
liver injury of rats, providing further support for the treatment of
hepatic injury attributing to PM. This study is the first systematic
analysis of TCM compatibility to reduce liver injury induced by
PM/LPS with endophenotype and metabolism researches.
MATERIALS AND METHODS
Chemicals and Reagents
Lipopolysaccharide derived from Escherichia coli serotype
055:B5 was obtained from Sigma–Aldrich (Lot 113M4068V; St.
Louis, MO, USA). Sodium pentobarbital was purchased from
the Sigma–Aldrich (St. Louis, MO, USA). Alanine transaminase
(ALT), aspartate aminotransferase (AST), and total bile acid
(TBA) kits were purchased from the Jiancheng bioengineering
institute (Nanjing, China). Enzyme-linked immunosorbent assay
(ELISA) kits for rat interleukin 1 beta (IL-1β), interleukin
6 (IL-6), interleukin 12 beta (IL-12β), interleukin 18 (IL-
18), interleukin 27 (IL-27), interferon gamma (IFN- γ), and
tumor necrosis factor-α (TNF-α) were obtained from Cloud-
Clone Corp. (Houston, TX, USA). Proteinase K was purchased
from Sigma Chemical Company (Buchs, Switzerland). HPLC-
grade methanol and acetonitrile were purchased from Merck
(Darmstadt, Germany). Deionized water was prepared using a
Milli-Q water purification system Millipore (Bedford, MA, USA).
Other chemicals were of analytical grade and their purity was
above 99.5%.
Animals
Male Sprague−Dawley (S.D.) rats, aged 6−8 weeks and weighing
180 ± 20 g, were purchased from the Laboratory Animal Center
of the Academy of Military Medical Sciences (License No. SCXK
2007-004). Animals received food and water ad libitum under
standard husbandry conditions (22± 2◦C temperature, 60−80%
relative humidity and 12 h photoperiod). After one week of
acclimatization, rats were grouped for experiments. All animal
experiments were conducted in the Laboratory Animal center
of the 302 Military Hospital. Rats received humane care in
accordance with the National Institutes of Health guide for
the Care and Use of Laboratory Animal, and procedures were
approved by the Committee on the Ethics of Animal Experiments
of the 302 Military Hospital.
Preparation of Herb Extracts
Decoction pieces of PM were extracted twice with 8 volumes
of 50% (V/V) ethanol by cold soak for 24 h. The combined
extract was filtrated (15−20 µm) and concentrated under the
negative pressure, freeze-dried to yield a brown ethanol extract
with extraction rate of 15.7%. Decoction pieces of Poria were
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extracted twice with 12 volumes of boiling water under refluxing
for 100 min. The collected extract was evaporated by water-
bath, and then lyophilized. The extraction rate of Poria was
2.28%. Decoction pieces of Licorice were extracted with 10
volumes of boiling water using reflux method for two times with
extraction length of 1 and 0.5 h, respectively. The combined
extract was filtered and concentrated by reducing pressure, and
dried by lyophilization. The extraction rate of Licorice was
23.58%. Decoction pieces of Panax notoginseng were extracted
with 10 volumes of boiling water using reflux method for two
times with extraction length of 2 and 1 h, respectively. Combined
filtrates were condensed by decompressing and freeze-dried. The
extraction rate of Licorice was 37.17%.
Experimental Design
Herbal compatibility has long been demonstrated to be a reliable
choice (Wang et al., 2012; Lam et al., 2015). Some promising
candidates including Poria, Licorice, and Panax notoginseng have
been selected to reduce the PM-induced liver injury. According
to previous studies, PM combined with middle dose of Poria has
been found to alleviate liver injury effectively. Furthermore, in
aiming to gain a better insight into detoxification metabolism
by herb compatibility and identify possible biomarkers for
predicting PM-induced liver injury, the comprehensive and
untargeted plasma metabolomics approach along with pattern
recognition analyses was designed to characterize potential
targets, determine the possible pathways and infer the biological
processes by UPLC-Q-TOF-MS.
Detoxification by Compatibility Test
Rats were randomly divided into thirteen groups (n = 9 per
group): control group (Ctr), LPS model group (LPS), PM-treated
group (PM), Poria-treated group (Por), Licorice -treated group
(Lic), Panax notoginseng-treated group (Pan), LPS group treated
with PM (LPM), LPS group treated with Poria (LPor), LPS
group treated with Licorice (LLic), LPS group treated with Panax
notoginseng (LPan), LPS group co-treated with PM + Poria
(LPP), LPS group co-treated with PM + Licorice (LPL), LPS
group co-treated with PM + Panax notoginseng (LPN), coming
down to three types, namely: control, model and herb groups.
After 12 h of fasting with free access to water, rats were received
intragastric administration of water (as control) or 1.08 g/kg PM,
0.81 g/kg Poria, 0.81 g/kg Licorice, 0.81 g/kg Panax notoginseng
dissolved in water (as herb groups according to the treatment
commonly used in clinic). Three hours later, rats were given
2.8 mg/kg LPS solution to model groups (with LPS groups) by
tail intravenous injection. Dose of LPS was selected according to
previous dose-response studies that did not cause a significant
increase of ALT and AST activity (Li C.Y. et al., 2015). Seven
hours later, rats were anesthetized with sodium pentobarbital
(50 mg/kg i.p.) to collect samples.
Compatible Proportion Test
Rats were divide into the following nine groups (n= 9) randomly:
control group (Ctr), LPS model group (LPS), LPS group treated
with PM (LPM), LPS group treated with high dose of Poria
(LHP), LPS group treated with middle dose of Poria (LMP), LPS
group treated with low dose of Poria (LLP), LPS group co-treated
with PM+ high dose of Poria (LPHP), LPS group co-treated with
PM + middle dose of Poria (LPMP), LPS group co-treated with
PM + low dose of Poria (LPLP). Rats fasted for 12 h only
with water ad libitum were received intragastric administration
of water only as control and 1.08 g/kg PM, high dose of Poria
(1.08 g/kg), middle dose of Poria (0.54 g/kg), low dose of Poria
(0.27 g/kg) for the compatible proportion of PM and Poria 1:1,
2:1, and 4:1. Experiment was processed on the same way as before.
Sample Collection
Rat plasma was collected with a syringe containing sodium citrate
by drawing blood from the vena cava under anesthesia, then
stored at −80◦C for further analysis. The liver tissues were
either stored with RNA store reagent overnight at the 4◦C,
then preserved at −80◦C for PCR or excised and immersed
immediately in 4% paraformaldehyde to fix for 4−6 h at room
temperature followed by overnight immersion in 15% sucrose.
Plasma Biochemical Determination
Hepatic parenchymal cell injury was estimated by evaluating
plasma ALT, AST activity, and TBA content using the Hitachi
clinical analyzer 7020 (Hitachi High-Technologies Co., Japan).
Inflammatory microenvironment was assessed by measuring
plasma inflammatory cytokines including IL-1β, IL-6, IL-12β, IL-
27, IFN- γ, and TNF-α content using ELISA kits according to the
manufacturer’s protocol.
H&E Staining and TUNEL Assay
The liver samples were embedded in paraffin after fixation, and
tissue sections (5 µm) were cut and processed for histological and
immunohistochemical analyses. H&E staining was performed
according to the standard H&E protocol.
Terminal deoxynucleotidyl transferase dUTP nick end
labeling (TUNEL) assay identified apoptotic cells by detecting
DNA fragmentation through a combination of enzymology and
immunohistochemistry techniques. It was performed using the
In Situ Cell Death Detection Kit, POD (Roche, Indianapolis, IN,
USA) based on the instructions of the manufacturer. Detailed
operations can be acquired in the Supplementary information.
Cells stained by TUNEL were captured with fluorescence
microscopy (Nikon Eclipse Ti-SR) equipped with a digital
camera (Nikon DS-U3).
RNA Isolation and Real-Time RT-PCR
Liver tissue was disrupted in liquid nitrogen, and total RNA was
prepared using an RNeasy Mini Kit (Qiagen, Hilden, Germany)
which included DNaseI digestion to remove any contaminating
genomic DNA according to the manufacturer’s instruction.
The purity and integrity of isolated RNA were determined
by measuring the relative absorbance at 260 and 280 nm,
respectively. Only RNA samples with 260/280 ratio between 1.8
and 2.1 were used for subsequent analyses.
For Reverse Transcriptase-real time quantitative Polymerase
Chain Reaction (RT-qPCR), 1 µg of total liver RNA was reverse-
transcribed to cDNA using RevertAidTM First Strand cDNA
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Synthesis Kit (Thermo Scientific, USA) in 20 µl following the
manufacturer’s protocol. After 1:25 dilution, 5 µl of the cDNAs
were used as templates in Maxima SYBR Green qPCR (Thermo
Scientific, USA) assays with a ABI 7500 Real-Time PCR System
and 7500 System Software (Applied Biosystems, Alameda, CA,
USA) to analyze IL-1β, IL-6, IL-12, IL-27, IFN-γ, and TNF-α gene
expression, with conventional AB cycling parameters (40 cycles
of 95◦C,15 s, 60◦C, 1 min). The melting curves were analyzed at
60−95◦C after 40 cycles to determine to purity. Glycer-aldehyde
3-phosphate dehydrogenase (GAPDH) was used as an internal
reference and each RT-qPCR analysis was performed in triplicate.
Primer sequences were designed using Primer Express shown in
Supplementary Table S1.
Plasma Preparation and UPLC-MS
Analysis
Prior to the analysis, 300 µl of plasma samples (Ctr, LPS, LPM,
LPMP groups) were put into individual 2-ml microcentrifuge
tubes after being thawed at room temperature. All samples
were extracted by adding 900 µl of acetonitrile, vortex-mixed,
centrifuged subsequently for 10 min at 21,000 g at 4◦C. Each
supernatant was carefully separate into vials and filtered by
0.22 µm microfiltration membrane for metabolomics analysis.
Metabolomics was performed on Agilent Technology iFunnel
6550 Q-TOF LC/MS. Chromatographic separation and mass
spectrometry were described in the Supplementary information.
Identification of the Metabolites and
Metabolic Pathway Analysis
Endogenous metabolites that contributed to the classification
were found by variable importance in the projection (VIP)
values, which showed the importance of each variable to the
classification. Only VIP values >1 were selected and used
for further data analysis. With regard to the identification of
biomarkers that were selected by changing significantly (p value
<0.05 and folder change >2), the ion spectrum was matched
with the structure message of metabolites acquired from available
biochemical databases, such as METLIN1, HMDB2, and KEGG3.
The pathway analysis of potential biomarkers was performed to
determine the relevant metabolic pathways with MetaboAnalyst
3.04 based on the library of Rattus norvegicus (rat).
Statistical Analysis
All the data were expressed as mean ± standard errors of the
mean (SEM) and analyzed using the Statistical Package for the
Social Sciences of Windows, version 17.0 (SPSS Inc, Chicago, IL,
USA). An ANOVA with Duncan’s multiple-range test (p < 0.05)
was used for statistical analysis.
Metabolite profiles from the UPLC-MS analysis were
converted into Agilent MassHunter Workstation LC-
TOF and QTOF Acquisition software (B.02.01) for data
acquisition. All chromatographic data from plasma was
1https://metlin.scripps.edu/
2http://www.hmdb.ca/
3http://www.genome.jp/kegg/
processed by the freely available software package MZmine
2.20 (http://mzmine.sourceforge.net/), which performed peak
noise removal, peak detection, and alignment in an automated
and unbiased way using mzdata file from Agilent Mass Hunter
Workstation Data Acquisition. The intensity of each ion was
normalized with respect to the total ion count to generate a
data matrix, and all these data matrices were introduced to
the SIMCA-P 11.0 version (Umetrics AB, Umea, Sweden) for
multivariate statistical analyses including principal component
analysis (PCA) and orthogonal partial least-square-discriminant
analysis (OPLS-DA) which was utilized to validate the PCA
model and identify the differential metabolites. Pathway analysis
was performed by the combination of a free web-based tool
MetaboAnalyst and the topology with a powerful pathway
enrichment analysis.
RESULTS
Poria Attenuates Liver Injury Induced by
PM-treated LPS Groups
Firstly, to compare the detoxification effects of different herbs,
we measured the plasma ALT, AST activity, and TBA content
reflecting functional liver damage. As Figure 1 indicated, the ALT,
AST activity, and TBA content did not increase markedly in the
LPS group compared to the Ctr, which proved that the dose of
LPS did not cause the significant liver injury in rats at the time
of sacrifice. In the meantime, rats consuming these four herbs
alone almost did not alter the liver function which was indicated
by the similar values of plasma ALT, AST, and TBA compared to
the Ctr. However, the average concentration of plasma ALT, AST,
and TBA were generally increasing after injection of LPS. This
elevation was further exacerbated in LPM groups compared to
those in the Ctr or LPS alone (P < 0.05), indicating the severity
of hepatic injury and cholestasis caused by PM/LPS. Afterwards,
we further focused on studying the detoxification effect of PM +
Poria co-treated with LPS (LPP), PM + Licorice with LPS (LPL),
and PM + Panax notoginseng with LPS (LPN), respectively. As
shown in Figure 1, plasma AST and TBA in LPN decreased
slightly compared to the LPM group. However, when compared
to the Ctr, LPN group showed significant increase in plasma ALT,
AST, and TBA. As for the compatibility of Licorice, levels in
LPL group were lower in three biochemical parameters than the
LPM group. There were even no significant differences of ALT
and TBA compared to the Ctr. Surprisingly, LPP group showed
markedly lower in plasma ALT, AST, and TBA than LPM group,
and no significant difference was observed compared to the Ctr.
Together, these data demonstrated Poria was more efficient than
either Licorice or Panax notoginseng in relieving liver injury
induced by PM based on LPS.
Compatible Proportion of PM and Poria
as 2:1 Suppresses Liver Injury the Best
As expected, plasma aminotransferase ALT and AST levels and
TBA content increased significantly after LPS administration in
LPM group. In rats co-treated PM with different proportions
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FIGURE 1 | The Plasma biochemical indicators in the absence and presence of LPS with PM and herbs including Poria (Por), Licorice (Lic), Panax
notoginseng (Pan). Rats were firstly treated with various herbs. After three hours, groups with LPS received 2.8 mg/kg LPS at caudal vein. (A,B) Blood samples
were taken at 7 h after the administration of LPS, and plasma ALT and AST levels were measured. (C) Plasma TBA content were measured in the same conditions.
The results were expressed as mean ± SEM (n = 9). Mean values followed by the same letter are not significantly different (P < 0.05) as determined by Duncan’s
multiple-range test.
FIGURE 2 | The Plasma biochemical indicators in different dose of Poria compatible test, specifically shown as control group (Ctr), LPS model group
(LPS), PM treated with LPS group, high dose of Poria treated with LPS group, middle dose of Poria treated with LPS group, low dose of Poria treated
with LPS group, PM + high dose of Poria co-treated with LPS group, PM + middle dose of Poria co-treated with LPS group, PM + low dose of Poria
co-treated with LPS group. Rats were firstly treated with different compatible proportion of herbs before three hours received LPS 2.8 mg/kg at caudal vein. (A,B)
Blood samples were taken at 7 h after the administration of LPS, and plasma ALT and AST levels were measured. (C) Plasma TBA content were measured in the
same conditions. The results were expressed as mean ± SEM (n = 9). Mean values followed by the same letter are not significantly different (P < 0.05) as
determined by Duncan’s multiple-range test.
of Poria, the elevation of these biochemical markers were all
significantly attenuated to different extends, especially with the
dose of Poria 0.54 g/kg, which could fully rescue the levels of
biochemical markers to normal (Figure 2). We concluded that
this moderate proportion (2:1) of PM-to-Poria worked best in
relieving liver injury induced by PM based on LPS.
Both Compatible Proportion of PM and
Poria as 2:1 and 4:1 Prevent the
Elevation of PM/LPS-Induced Systemic
Inflammation
Polygoni Multiflori Radix Praeparata led to liver injury in the
presence of acute LPS and LPS played a fundamental role in
systemic inflammatory response and multiple organ dysfunctions
including liver. We thus hypothesized that PM/LPS might
enhanced the production of inflammatory cytokines whereas
Poria could counteract these effects. Changes in plasma cytokines
collected from PM/LPS groups with different proportions of
Poria were shown in Figure 3. LPS challenge caused increases
in levels of the inflammatory cytokines including IL-1β, IL-6,
IL-12β, IL-27, TNF-α, and IFN-γ compared with the Ctr, and
among which the changes of IL-1β and IFN-γ showed significant
differences (P < 0.05). Compared with the LPS-alone group,
TNF-α and IFN-γ increased markedly while IL-1β and IL-27
increased slightly in the LPM group. Different doses of Poria-
treated with LPS almost did not result in any significant changes
in inflammatory cytokines levels compared to LPS group. By
contrast, middle dose or low dose of Poria and PM co-treated
with LPS ameliorated systemic inflammation, which was well
demonstrated by significantly decreased levels of TNF-α and
IFN-γ.
Poria Reduced PM/LPS-Induced
Intrahepatic Inflammatory Cytokines
mRNA Expression
Plasma cytokine levels are not representative enough for
the assessment of inflammatory processes within the liver,
possibly due to the stronger influence directly from the
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FIGURE 3 | Plasma inflammatory cytokine levels determined by ELISA. Groups and methods of administration were the same as described in Figure 2. The
data were expressed as mean ± SEM of nine rats. Mean values followed by the same letter are not significantly different (P < 0.05) as determined by Duncan’s
multiple-range test.
FIGURE 4 | Plasma inflammatory cytokine levels determined by RT-qPCR. Groups and methods of administration were the same as described in Figure 2.
The data were expressed as mean ± SEM of nine rats. Mean values followed by the same letter are not significantly different (P < 0.05) as determined by Duncan’s
multiple-range test.
Frontiers in Pharmacology | www.frontiersin.org 6 October 2016 | Volume 7 | Article 386
fphar-07-00386 October 14, 2016 Time: 13:1 # 7
Gao et al. Poria Attenuates Liver Injury
FIGURE 5 | Histopathological damage in rat liver. (A) Control group (Ctr), (B) LPS model group (LPS), (C) PM treated with LPS group (LPM), (D) high dose of
Poria treated with LPS group (LHP), (E) middle dose of Poria treated with LPS group (LMP), (F) low dose of Poria treated group with LPS (LLP), (G) PM + high dose
of Poria co-treated with LPS group (LPHP), (H) PM + middle dose of Poria co-treated with LPS group (LPMP), (I) low dose of Poria co-treated with LPS group
(LPLP). Liver sections were collected at 7 h after LPS tail intravenously (HE stained, ×200 magnification).
blood stream such as leukocytes to the plasma cytokine
levels (Ohira et al., 2009). Therefore, we determined the
capacity of Poria to prevent the intrahepatic expression of
inflammatory cytokines based on the PM/LPS model by RT-
qPCR. Interestingly, although Poria did not distinctly change
the PM/LPS-induced systemic inflammation release of different
cytokines detected by ELISA, i.e., IL-1β, IL-6, IL-12β, and
IL-27, Poria significantly inhibited intrahepatic expression of
all those inflammatory cytokines including IL-1β, IL-6, IL-
12p40, IL-27, TNF-α, and IFN-γ. As Figure 4 indicated,
cytokines mRNA levels increased markedly (P < 0.05) in
LPM groups compared to LPS group. When Poria and
PM were co-treated with LPS, most of cytokines mRNA
expressions were significantly lowered except for the TNF-
α in high dose of Poria (1.08 g/kg) to the PM/LPS-induced
increase (LPHP). The levels of IL-12p40, IL-27, TNF-α,
and IFN-γ were reversed to normal level by the treatment
of PM and Poria 2:1which did somewhat better than
that of 4:1.
Hepatic Histopathology and Apoptosis
H&E staining analysis of liver sections revealed intact lobular
architecture and normal hepatocyte structure in the Ctr
(Figure 5A). Rats from LPS-treated alone group showed evidence
of mild pathological alteration such as moderate invasion of
inflammatory cells in portal area around the vessels, low level
of proliferation and enlargement of Kupffer cells, indicating
the activation of inflammatory signaling pathways (Figure 5B).
In Poria/LPS-treated animals, hepatic sinus expansion, mild
inflammatory cell infiltration and perivascular cells in irregularly
vacuolar degeneration were observed (Figures 5D–F). However,
there were significant pathological changes in PM/LPS groups
in following manners: (a) hepatic sinus expanded significantly
near the central vein; (b) part of the hepatocytes showed visible
swelling; (c) some cells have no nuclei even dot necrosis; and d)
high level of inflammatory cells infiltration in portal area around
the vessels (Figure 5C). Interestingly, the combination of middle-
and low-dose of Poria and PM prior to LPS exposure ameliorated
these pathological changes, resulted in significant morphological
Frontiers in Pharmacology | www.frontiersin.org 7 October 2016 | Volume 7 | Article 386
fphar-07-00386 October 14, 2016 Time: 13:1 # 8
Gao et al. Poria Attenuates Liver Injury
FIGURE 6 | Hepatocyte apoptosis in rat by TUNEL assay. (A) Control group (Ctr), (B) LPS model group (LPS), (C) PM treated with LPS group (LPM), (D) High
dose of Poria treated with LPS group (LHP), (E) Middle dose of Poria treated with LPS group (LMP), (F) Low dose of Poria treated group with LPS (LLP), (G) PM +
high dose of Poria co-treated with LPS group (LPHP), (H) PM + middle dose of Poria co-treated with LPS group (LPMP), (I) low dose of Poria co-treated with LPS
group (LPLP). Liver sections were collected at 7 h after LPS tail intravenously.
protection against PM/LPS induced liver damage. However, the
administration of high dose of Poria did not significantly change
the histological appearances of livers compared with the PM/LPS
group (Figures 5G–I).
To confirm that Poria prevented liver injury, we performed
TUNEL assays on liver sections (Figure 6). We did not observe
any TUNEL-positive hepatocytes in the Ctr, whereas following
LPS treatment, rat liver displayed some. Furthermore, a large
number of cells showed TUNEL-positive in PM/LPSwith the
clearly vacuolar degeneration. LPS group treated with high-dose
of Poria led to more apparently positive TUNEL reaction than
middle- and low-doses, suggesting that high-dose of Poria might
aggravate hepatocyte apoptosis in the presence of LPS. When
we administered three different doses of Poria with PM before
LPS, both middle- (0.54 g/kg) and low-doses (0.27 g/kg) of Poria
decreased hepatocyte apoptosis dramatically, and the middle-
dose performed better. Numbers of apoptotic hepatocytes were
similar between LPHP group and LPS. Taken together, these
results indicated that the compatible proportion of PM and
Poria 2:1 attenuated PM/LPS-induced hepatocyte apoptosis more
effectively than other two doses.
Metabolic Profiling and Biomarkers
Identification
Metabolic profile of plasma samples was acquired using UPLC-
QTOF/MS in positive and negative ESI modes and low molecular
weight metabolites were represented as chromatographic peaks.
The data containing the retention time, peak intensity and exact
mass were imported into the MasslynxTM software for multiple
statistical analyses. Both PCA and OPLS-DA could be taken due
to their ability of coping with highly multivariate, noisy, collinear
and possibly incomplete data.
As the compatible proportion of PM and Poria 2:1 suppressed
liver injury induced by PM/LPS worked the best, the Ctr,
LPS, LPM, and LPMP groups were specifically selected to
get a classification. The PCA analyses were performed as
an unsupervised statistical method to visualize inter-group
metabolic differences, where each point represented an individual
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FIGURE 7 | Principal component analysis scores plot of comparing Ctr, LPS, LPM, and LPMP groups in positive ESI modes (A) and negative ESI
modes (B).
sample, and the distance between them reflected the scale of their
metabolic differences. As the PCA score plot shown in Figure 7,
the LPM group was clearly separated from the other three groups,
indicating that marked alteration of plasma metabolites appeared
in rats by PM-treated with LPS. While with middle dose of
Poria treatment, the metabolic patterns of rats were closest to
the Ctr, indicating recovery of metabolic feature and pathological
improvements.
Orthogonal partial least-square-discriminant analysis was
applied to better understand the different metabolic patterns and
gave rise to identify potential biomarkers that were significantly
changed between LPS and herbs groups. Quality of resulting
discriminant models were summarized in Supplementary Table
S2. The key model parameters, R2 and Q2 in pair-wise groups
were all larger than 0.5, suggesting robust fit and prediction
of all the models. Score plots from the supervised OPLS-DA
showed clear separation between the LPS and LPM groups, or the
LPM and LPMP groups in both positive (Supplementary Figure
S1) and negative ion modes (Figures 8A,B; Supplementary
Figures S1A,B), suggesting a significant plasma biochemical
perturbation in the LPM group. From the corresponding S-plots,
variables further away from the origin were considered to
contribute more significantly, thus they were more responsible
for the separation between aforementioned groups. These
variables may therefore be regarded as potential biomarkers
(Figures 8C,D; Figures S1C,D). Variables determined by
variable importance for projection (VIP) value >1 were pre-
screened as potential biomarkers. To decrease the rate of false
positives in the selection, variables with |p(corr)| ≥ 0.5 were
selected.
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FIGURE 8 | The OPLS-DA score plots and S-plots generated from the OPLS-DA of the QTOF/MS data from LPS, LPM, and LPMP groups in the ESI-
mode. OPLS-DA score plots were the pair-wise comparisons between the LPS and LPM (A) as well as the LPM and LPMP (B). S-plot of the OPLS-DA model were
for the LPS and LPM (C) and the LPM and LPMP (D), which axes are plotted in the S-plot from the predictive component are p1 vs. p(corr)1, representing the
magnitude (modeled covariation) and reliability (modeled correlation), respectively. The points in red indicate the identified biomarkers.
Co-metabolites that differed significantly (p < 0.05) in
the LPM group compared with the LPS group as well as the
LPMP group were selected as potential biomarkers. Criterion
was restricted to feature with an average normalized intensity
difference of 1.5-fold. Then, metabolites in the ESI+ and
ESI− mode analyses were combined and subjected to further
identification of their molecular formulas. All biomarkers were
tentatively identified with the accurate mass charge ratio by
the online METLIN database1. To determine the potential
structures of the ions, targeted MS/MS analysis was applied
to identify the metabolites. In the evaluation of the LPS and
LPM groups to seek biomarker of PM-induced liver injury
with non-injurious LPS in rats, fourteen metabolites were
significantly (p < 0.05) altered, and they were summarized
in Table 1 with corresponding retention time, m/z, formula
and trend. Intriguingly, the compatible proportion of PM
and Poria 2:1 induced the most dramatic metabolic changes
with thirteen metabolites of them. Through comparison,
we found that ten of the fourteen biomarkers (creatine,
arginine, sphingosine, sphinganine 1-phosphate, adrenoyl
ethanolamide, ornithine, 4-aminobutyraldehyde, uridine,
taurocholate, glycocholate) were significantly altered and even
normalized compare to the Ctr. This result was consistent
with the observed improvements in biochemical parameters
and histological findings, suggesting the potential of these
metabolites to be developed as biomarkers for improved liver
damage.
Biological Pathway Analysis of Identified
Biomarkers
In the present study, ten metabolites were expressed at
significantly different levels. Arginine, sphinganine 1-
phosphate, adrenoyl ethanolamide, ornithine, creatine, and
4-aminobutyraldehyde were up-regulated while sphingosine,
uridine, taurocholate, and glycocholate were down-regulated
when Poria attenuated liver injury induced by PM/LPS in rats. To
further reveal the relationship among these distinct biomarkers,
we targeted nine potential metabolic pathways (Supplementary
Table S3). Top three of importance included arginine and proline
metabolism, primary bile acid biosynthesis and sphingolipid
metabolism as shown in Figure 9.
DISCUSSION
Previous study has been proposed that inflammatory stress may
render an individual with higher susceptible to idiosyncratic
adverse drug reactions. Indeed, some idiosyncratic drug-induced
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TABLE 1 | Differential metabolites for discrimination among lipopolysaccharide (LPS), LPS group treated with PM (LPM), and LPS group co-treated with
PM + middle dose of Poria (LPMP) groups.
No. Metabolite Mass tR/min Formula LPM/LPS LPMP/LPM
VIP Fold p VIP Fold p
ESI+ mode
1 Creatine 131.0692 0.82 C4H9N3O2 1.67 0.63 0.0084 1.53 1.70 0.0254
2 Arginine 174.1124 0.93 C6H14N4O2 5.55 0.52 0.0052 5.76 1.92 0.0004
3 Sphingosine 299.2812 13.44 C18H37NO2 1.12 2.58 0.0086 1.11 0.45 0.0142
4 Sphinganine 1-phosphate 381.2663 19.72 C18H40NO5P 1.29 0.43 0.0194 1.21 2.08 0.0009
5 Disopyramide 339.2319 19.92 C21H29N3O 1.08 0.22 0.0140 0.93 3.63 0.0030
6 Adrenoyl ethanolamide 375.3123 21.08 C24H41NO2 1.61 0.47 0.0080 1.62 2.10 0.0009
ESI− mode
7 Ornithine 132.0853 1.05 C5H12N2O2 5.83 0.48 0.0005 5.56 1.77 0.0106
8 4-Amino-butyraldehyde 87.0684 1.28 C4H9NO 1.01 0.37 0.0022 1.14 2.52 0.0049
9 4-Pyridoxic acid 183.0502 1.36 C8H9NO4 2.22 0.58 0.0168 1.92 1.55 0.0941
10 4-Acetamid-obutanoate 145.0739 1.77 C6H11NO3 2.44 0.52 0.0114 1.27 1.42 0.2873
11 Phenyl sulfate 174.0012 5.58 C6H6O4S 3.25 0.17 0.0400 1.72 3.36 0.7962
12 Uridine 122.0321 5.75 C9H12N2O6 1.47 2.06 0.0315 2.24 0.37 0.0141
13 Taurocholate 515.2905 7.75 C26H45NO7S 1.04 2.66 0.0460 1.32 0.32 0.0317
14 Glycocholate 465.3040 8.17 C26H43NO6 1.17 1.95 0.0491 1.33 0.52 0.0361
FIGURE 9 | Summary of pathway analysis with MetaboAnalyst 3.0:
(a) Arginine and ornithine metabolism; (b) Arginine and proline
metabolism; (c) Sphingolipid metabolism; (d) Primary bile acid
biosynthesis.
liver injury (IDILI) have been developed in LPS/drug models
that support this inflammatory stress hypothesis (Kaplowitz,
2005; Waring et al., 2006; Roth and Ganey, 2011). In the
present study, our data indicated single Chinese herb (PM,
Poria, Licorice, or Panax notoginseng) or LPS alone did not
effectively increase the clinically used biomarkers of liver damage
or cause any lesions in the liver as confirmed by biochemical
and histological examinations. However, in PM/LPS rats, plasma
markers of hepatocytes injury including ALT, AST, and TBA
were increased significantly while none of Poria, Licorice or
Panax notoginseng treated with LPS had the similar effect.
These data vigorously proves that PM induces the idiosyncratic
hepatotoxicity based on LPS model which is highly consistent
with our team’s previous proposal of immunological stress-
mediated idiosyncratic liver injury induced by PM (Wang et al.,
2016).
Duality is a nature of most drugs with both wanted and
unwanted effects at the same time. TCM is no exception.
However, with the goal of counteracting toxicities and/or
enhancing the therapeutic effects, drug compatibility has shown
its unique significance to handle this problem in long-
term clinical practices since ancient times. Interestingly, our
compatibility test showed when co-treated with Poria, PM
reversed its hepatotoxicity. In the meantime, Poria showed the
best compatibility effect than any other candidates, especially
with the optimal proportion of PM and Poria 2:1. This is the
first study to ever report the reasonable compatibility of Poria
could play a role of attenuating idiosyncratic toxicity induced by
PM/LPS.
Recent evidences from experimental models indicate that
mild inflammatory microenvironment may markedly increase
the susceptibility of individuals to drugs with hepatotoxic
effects and a toxic reaction would not occur in normal
body (i.e., an “idiosyncratic” response) (Waring et al., 2006;
Deng et al., 2009). In LPM group, levels of inflammatory
cytokines increased markedly than any other groups while
they were significantly ameliorated fully proved by plasma
ELISA and liver RT-qPCR analyses. Besides, several studies
have demonstrated anti-inflammatory activities of Poria.
Specifically, Jeong et al. (2014) showed ethanol extract of
Poria reduced the production of inflammatory mediators
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FIGURE 10 | Schematic diagram of the disturbed metabolic pathway related to PM and Poria treatment based on the LPS model. (↑) in red represents
metabolite increase and (↓) in blue is metabolites reduce. The related metabolic pathway is marked in gray bold.
by suppressing the NF-kappaB signaling pathway in LPS-
stimulated RAW 264.7 macrophages (Fuchs et al., 2006). As
Poria played hepatoprotective effects against PM-induced
liver injury in the inflammatory stress, it was reasonable to
suggest that Poria about half dose of PM might diminish
the liver susceptibility by improving the inflammatory
microenvironment.
Herbal medicines have recently been recognized as the major
cause of drug-induced liver injury (DILI) (Wang et al., 2015).
Herbs are often characterized as multi-component and multi-
target. Thus, DILI diagnosis is difficult due to the lack of
definitive operation standards and methods, let alone IDILI
with the concealed feature. Metabolomics, focused on the
comprehensive analysis of endogenous metabolites within the
integrated biological systems, is a powerful technique to develop
predictive biomarkers related to prognosis or diagnosis of a
disease or drug toxicity/efficacy (Guma et al., 2016). Here,
our LC-MS-based metabolomics investigation of the plasma
revealed that metabolic perturbation occurred in LPM group
and Poria co-administration attenuated this perturbation. Ten
metabolites were expressed differentially among LPS, PM/LPS,
and detoxification-treated groups. Affected metabolites were
tightly correlated with arginine and proline metabolism, primary
bile acid biosynthesis and sphingolipid metabolism. Summary
of those proposed pathways was displayed in Figure 10. System
analysis of metabolic networks that are a central paradigm
in biology will help us to identify potential biomarkers for
developing new diagnostic and therapeutic strategies and provide
insights into molecular mechanisms of how Poria exerts effective
treatment to PM/LPS-induced hepatotoxicity.
The liver is responsible for bile formation and biliary secretion
(Schadt et al., 2016). Thus, any changes of bile acid homeostasis
might be linked to various types of liver injury. In this study,
plasma biochemical parameters reflected loss of hepatic functions
with the significant elevation in the level of ALT, AST, and
TBA, indicating that the hepatic injury caused by PM/LPS
could influence bile acid metabolism. This was not surprising
as liver disease has been reported to disturb the synthesis,
metabolism, clearance and intestinal absorption of hepatic bile
acids (Bobeldijk et al., 2008; Alnouti, 2009). Comparing LPS
group with LPM in metabolites, the levels of taurocholate and
glycocholate derived from TBA rose significantly, while which
reduced greatly in LPP group, demonstrating the efficacy of Poria
in ameliorating the changes of TBA metabolites. In fact, Luo
et al. have evaluated cholic acid, taurocholate, and glycocholate as
potential biomarkers of liver injury in rodent models by a targeted
LC-MS/MS approach to differentiate various types of liver injury
(Luo et al., 2014). Therefore, alterations in TBA profiles can be the
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consequence of hepatotoxicity. In addition, Allen et al. showed
bile acids could induce up-regulation of inflammatory genes
expression in hepatocytes after bile duct ligation, which may
promote hepatic inflammation during obstructive cholestasis and
contribute to DILI (Allen et al., 2011).
Arginine, a versatile amino acid in animals, serves as a
precursor for ornithine, urea, nitric oxide, and creatine. It has
been suggested as a biomarker candidate for liver injury which
has been found decreased in hepatic injuries by hepatotoxicants
such as thioacetamide and carbon tetrachloride (Saitoh et al.,
2014). Rats in LPM group exhibited significant reduction of
plasma creatine, arginine, ornithine, and 4-aminobutyraldehyde,
suggesting a disturbance of arginine and ornithine metabolism.
Indeed, Saitoh et al. (2014) confirmed that arginine-to-ornithine
pathway was altered in association with acute hepatic injury, and
plasma arginine and ornithine were possibly specific biomarkers
for liver injury. Interestingly, creatine synthesis is initiated
by arginine glycine amidinotransferase (AGA) that transforms
arginine to ornithine. Since AGA has been reported to be
located in the liver, the decreased blood creatine levels might
contribute to the alterations in blood arginine and ornithine
following liver injury (Wu and Morris, 1998). Nicholson et al.
also demonstrated creatine and creatinine could reflect the injury
of both liver and kidney (Nicholson et al., 2002). Additionally,
inflammatory stimuli (e.g., LPS) greatly stimulated the expression
of arginase I, arginase II, and ornithine decarboxylase in many
cell types (Morris, 2007). Therefore, these increased substances
upregulated arginine metabolism for the synthesis of urea,
ornithine, proline, and polyamines in response to inflammation.
In contrast, concentrations of arginine, ornithine and 4-
aminobutyraldehyde in LPM plasma were reduced markedly
suggesting the disorder of arginine and ornithine metabolism.
Sphingolipids are critical regulators of hepatic homeostasis
and contribute to the progress of several liver diseases (Mari
and Fernandez-Checa, 2007). They are structural components
of biological membranes bilayer presenting as a diverse
class of lipids including free sphingoid bases and their
phosphates such as sphingosine and sphinganine-1-phosphate
(Grammatikos et al., 2014). Recently, sphinganine-1-phosphate
has been reported as a mediator of liver regeneration after
injury (Nojima et al., 2015). In this study, the decreased
concentration of sphinganine-1-phosphate and the rising of
sphingosine in the LPM group signified that the LPM-injured
rats might lose the homeostasis of normal metabolite. On
the contrary, the concentrations of sphinganine-1-phosphate
and sphingosine were recovered in LPP group, and the liver
of rats could be concomitantly protected. Moreover, TNF-
α and IL-1β are important mediators of liver inflammation
and injury (Chen et al., 1995). Studies indicate that the acyl
chain length and composition in sphingolipids play a crucial
role in regulating internalization of the TNF-α receptor-1 and
subsequent apoptosis signaling pathways in hepatocytes (Albi
et al., 2013). Ceramide generation could be stimulated by IL-
1β in hepatocytes (Chen et al., 1995), whose accumulation has
been implicated as an important contributing factor of liver
injury and apoptosis. In sum, the initiation and progression of
liver injury is multifactorial, and understanding of sphingolipid
metabolic pathway may open up a novel therapeutic avenue to
liver diseases.
CONCLUSION
Consistent with previous studies, we showed PM could induce
idiosyncratic hepatotoxicity in rats with modest inflammatory
episode triggered by non-injurious dose of LPS. Secondly, the
proper proportion of PM and Poria 2:1 effectively attenuated
idiosyncratic toxicity induced by PM/LPS. Finally, ten potential
biomarkers involved in three metabolic pathways including
arginine and proline metabolism, primary bile acid biosynthesis
and sphingolipid metabolism were identified by metabolomics.
Among these, inflammatory stress played an important role
in the initiation and progression of liver injury. The current
study provides the very first systematic experimental basis of
the hepatoprotective effects of Poria against PM/LPS-induced
liver injury. Although further studies are needed to validate
diagnostic and/or prognostic values of the identified potential
biomarkers, the present strategy provided insights into studying
the multifactorial molecular mechanisms of how Poria exerts
effective treatment to PM/LPS-induced liver injury.
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